| Registry | NCT06709378 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 9 (Actual) |
| Sponsor | Changzhou No.2 People's Hospital (Other) |
| Conditions | Dislocated Lens, Pars Plana Vitrectomy, Phacoemulsification, Needle |
| Dates | start 2022-07-01, primary completion 2024-09-01, completion 2024-09-01, first posted 2024-11-29, last updated 2024-11-29 |
| Locations | 1 site in China |
Related Papers Related Patents Related Grants Related Experts
All trials for Dislocated Lens All trials for Pars Plana Vitrectomy
The goal of this observational study is to learn about the effects of 25-gauge (G) needle-assisted phacoemulsification to remove dislocated intravitreal lens nuclei.
Patients with dislocated intravitreal lens nuclei who underwent 23G pars plana vitrectomy (PPV) and 25G needle-assisted phacoemulsification between July 2022 and September 2024 were included. Primary outcomes included best-corrected visual acuity (BCVA) and intraocular pressure (IOP). Secondary outcomes included corneal endothelial cell count (CECC) and the incidence of intraoperative and postoperative complications. These outcomes were statistically analyzed both preoperatively and postoperatively. A minimum follow-up of 6 months was completed for all eyes.
Sex: All
Inclusion Criteria: Clinical diagnosis of dislocated intravitreal lens nuclei Signed informed consent Exclusion Criteria: Surgical contraindications
| Facility | City | Country | Status |
|---|---|---|---|
| the Second People's Hospital of Changzhou | Changzhou, Jiangsu | China |